Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-01-27Clinical Trial Update: Standard Comprehensive Intervention to Treat First-episode Schizophrenia [NA]
A clinical trial update from Peking University on a comprehensive intervention for first-episode schizophrenia, with the current status list…
-
CLINICAL_TRIALS research · 2010-01-25Clinical Trial Update: A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia
A German multicenter clinical trial investigates the association between Toxoplasma gondii infection and first-episode schizophrenia. The up…
-
CLINICAL_TRIALS research · 2010-01-15Clinical Trial Update: Family-based Genetic Long-term Study of Brain Function in Schizophrenia
This entry provides an update on a family-based, long-term genetic study investigating brain function in schizophrenia, including MRI imagin…
-
CLINICAL_TRIALS research · 2010-01-14Clinical Trial Update: The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating two Traditional Chinese Medicines for clozapine-induced hypersalivation in patients with schizophrenia.
-
CLINICAL_TRIALS research · 2010-01-14Clinical Trial Update: Competence Ability Study in People With Schizophrenia
Clinical trial update describing a study on competence ability in people with schizophrenia; no results are included in the provided snippet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-01-12FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for risperidone filed by Zydus Lifesciences Limited, granting approval for a generic version und…
-
CLINICAL_TRIALS safety_alert · 2010-01-12Clinical Trial Update: Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine [Phase 4]
A Phase 4 clinical trial update reports heart rate changes in patients with schizophrenia or bipolar disorder treated with aripiprazole or q…
-
FDA approval · 2010-01-07FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approves a supplemental application for Fluphenazine hydrochloride from PAI Holdings/PAI Pharma.
-
CLINICAL_TRIALS research · 2010-01-06Clinical Trial Update: Cognitive Remediation for Schizophrenia [NA]
Clinical trial update shows the cognitive remediation study for schizophrenia has completed enrollment/status.
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women [Phase 4]
This clinical trial update notes the completion of a Phase 4 double-blind, placebo-controlled study evaluating raloxifene for negative sympt…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: SWitching to Abilify Trial (SWAT) [Phase 4]
Phase 4 clinical trial update reporting the completion of the SWAT trial evaluating switching to Abilify (aripiprazole) for schizophrenia. S…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) [Phase 4]
Phase 4 trial APLUS evaluating acute psychosis treatment in a long-term unitary group has completed. The study enrolled patients with schizo…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms [NA]
A completed Northwell Health trial evaluated a combination of an antidepressant and an antipsychotic for attenuated positive and negative sy…
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: Health Evaluation of Abilify Long-term Therapy [Phase 4]
Phase 4 clinical trial evaluating long-term Abilify (aripiprazole) therapy for schizophrenia and schizoaffective disorder has completed.
-
FDA approval · 2009-12-15FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone from ANI Pharmaceuticals, Inc., resulting in a generic risperidone product being…
-
FDA approval · 2009-12-11FDA Approved: ZYPREXA RELPREVV — Original Application (H2-Pharma LLC)
FDA approved ZYPREXA RELPREVV (olanzapine pamoate) under an Original Application, providing a long-acting injectable option for schizophreni…
-
FDA approval · 2009-12-09FDA Approved: HALOPERIDOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for HALOPERIDOL LACTATE from Hikma Pharmaceuticals USA Inc., authorizing modifications under the AND…
-
FDA approval · 2009-12-04FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA (olanzapine) filed by Eli Lilly and Company, expanding the regulatory scope of the produ…
-
FDA label_change · 2009-12-02FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC, likely involving changes to the drug's la…
-
FDA approval · 2009-12-02FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for a generic risperidone version manufactured by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2009-11-30Clinical Trial Update: Social Skills Training in Refractory Schizophrenia [NA]
Clinical trial update about social skills training for patients with refractory schizophrenia; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: A Comparison of Two Cognitive Batteries in People With Schizophrenia [NA]
This clinical trial record notes the completion of a study comparing two cognitive assessments in individuals with schizophrenia and schizoa…
-
CLINICAL_TRIALS research · 2009-11-26Clinical Trial Update: Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia [Phase 1]
This Phase 1 clinical trial investigating the effects of glycine on symptoms and memory in schizophrenia and schizoaffective disorder has be…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Treatment of Acute Schizophrenia With Vitamin Therapy [Phase 4]
A Phase 4 clinical trial evaluating vitamin therapy for acute schizophrenia has completed.
-
CLINICAL_TRIALS research · 2009-11-25Clinical Trial Update: Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study
An update on a descriptive and comparative clinical study examining factors influencing caregiver burden. It focuses on informal caregivers …